Serum chemokines in lupus nephritis and sle disease activity

الملخص EN

Objective : to estimate the serum macrophage inflammatory protein-1α (MIP-1α) and serum / urinary monocyte chemo attractant protein-1 (MCP-1) in systemic lupus erythematous (SLE) patients.

This is in order to highlight their possible roles in the pathogenesis of SLE, disease activity and renal involvement.

Methodology : Forty SLE patients (group I) and 20 apparently healthy controls (group II) were included in the study.

SLE patients were subdivided into group IA patients with active lupus nephritis (13 patients) and group IB patients without nephritis (27 patients).

Nephritis was diagnosed by active urinary sediments, impaired serum cretonne or cretonne clearance and graded by renal biopsy according to the WHO classification.

SLE activity was measured using SLEDAI.

The serum MIP-1 and serum / urinary MCP-1 were measured in all patients and controls using the ELISA technique.

Results : SLE patients had a significantly higher level of serum MIP-1in group IA (105.2 + 12.9 pgm / mL) and group IB (93.9 + 3.5 pgm/mL) when compared to the control group (69.1 + 4.9 pgm / mL).

Also, there was a significant positive correlation (p < 0.05) between MIP-Iand both clinical (SLEAI), serological (dsDNA, ESR levels) parameters of disease activity and serum / urinary MIP1.

There was a statistically significant difference between the means of MCP-1 (serum 16.40 + 5.97 and urinary 21.20 + 3.12) among the controls and SLE group IA (serum 488.6 + 354.61, urinary 590.3 + 339.54), also between the controls and SLE group IB (serum 32.20 + 12.65, urinary 35.5 + 18.55).

The serum and urinary MCP-1 showed positive correlation with disease activity (SLEDAI), serum cretonne, and cretonne clearance.

Also, urinary MCP-1 had positive correlation with ESR.

Again, there was a significant difference between groups IA and IB regarding serum levels of MIP-1α and serum / urinary MCP-1 (p < 0.05).

Conclusion : the levels of serum MIP-1α and the serum / urinary MCP-1, may be used as laboratory parameters of disease activity in SLE and may reflect its immunopathogentic role and proinflammatory activity in SLE.

Also, the urinary MCP-1 may be a useful simple tool for monitoring disease activity of lupus nephritis.